News and updates from the International Centre for Antimicrobial Resistance Solutions. | International centre for antimicrobial resistance solutions

News and updates from the International Centre for Antimicrobial Resistance Solutions.

Published

Dear friends and colleagues, 

We are pleased to present our quarterly edition of news and updates from the International Centre for Antimicrobial Resistance Solutions.

First and foremost, we invite you to read the ICARS Annual Report for 2021 which presents an accessible summary of ICARS’ key achievements across our four strategic pillars: testing solutions, translating evidence, advocacy and capacity building. In the run up to launching our annual report for 2021, we valued the chance to take stock of our progress and channel our reflections into developing our strategy for 2022-2026. The revised strategy, recently approved by our Board of Directors, will be launching in the coming months and we look forward to sharing it with you in the next newsletter edition.

Our research project portfolio continues to grow and mature, in April we launched two new projects in Tanzania, and celebrated JPIAMR’s launch of 19 new One Health intervention and transmission projects, some of which are co-funded by ICARS. Furthermore, following the launch of a joint RFP with IDRC at the start of the year, a project is now underway to develop guidance for integrating a gender lens in AMR research projects.

Aside from launching new solutions, it has also been great to see our existing projects progress, catch up on our recent trip to Vietnam, and stay tuned for future announcements about potential future projects in Laos, Zimbabwe, and Benin that are currently under co-development.

As you know, partnership is one of ICARS' core principles and it gives us great pleasure to welcome Georgia and India as ICARS Mission Partners. This formal agreement recognises their alignment with our vision and mission, commitment to tackle AMR in their countries, and opens the door to future collaborative efforts bolstered by valuable in-kind support.

As our output grows, so does our team and we are pleased to introduce Kristina Osbjerg to the Science Team as a Veterinary Advisor, with more positions being filled in the coming weeks. In addition, the World Bank have appointed Martien Van Nieukoop, Global Director, Agriculture and Global Food Practice as an Observor to the Board of Directors and we had the pleasure of welcoming him at the 10th of June Board meeting.

We thank you again for your interest in ICARS. Please feel free to share this newsletter with others within your network and invite them to subscribe here.

With all best wishes,
The ICARS Team

ICARS annual report 2021

ICARS made great strides in 2021 including establishing itself as a self-governing organisation, building a diverse portfolio of projects across Latin America, Asia, and Africa, and advocating for intervention and implementation research to tackle antimicrobial resistance (AMR) at multiple high-level events. The 2021 annual report presents ICARS’ key achievements across four strategic pillars: testing solutions, translating evidence, advocacy, and capability building. The report also shares governance and organisational updates, financial statements and introduces the core team, Board of Directors and Technical Advisory Forum.

Read more

Two new projects to tackle AMR launched in Tanzania

On 5 April 2022, the ICARS team met with representatives from the Ministry of Livestock and Fisheries, who shared a letter of commitment to support two demonstration projects in Tanzania, one in the animal and one in the environment sector. The Ministry will support the two projects throughout their duration, supporting scientific and oversight activities, as well as supporting the future scale up. The projects will be implemented by Sokoine University of Agriculture (SUA), in Morogoro Tanzania, and two grant agreements between ICARS and SUA were also signed at this meeting to solidify this collaboration.

Read more

New project launched to develop practical guidance on how to integrate a gender lens into AMR research projects

After a highly competitive proposal selection process ICARS and IDRC are pleased to announce that we have selected the Human Sciences Research Council (HSRC) and Jive Media Africa in South Africa along with the Mahidol Oxford Tropical Medicine Research Unit (MORU) at Mahidol University in Thailand to undertake the new gender and AMR project.

Read more

India joins ICARS as a Mission Partner

During the Danish visit of Shri Narendra Modi, Prime Minister of the Republic of India, it was announced that India will join ICARS as a Mission Partner. The formal partnership between India and ICARS demonstrates an expression of support to ICARS’ mission and vision, a commitment to actively working to mitigate AMR, and lays strong foundations for new context-specific and cost-effective solutions for reducing drug-resistant infections in India.

Read more

Georgia joins ICARS as a Mission Partner

ICARS’ collaboration with Georgia already reaches back to 2020, when we co-developed the first human health intervention in Georgia. The project, which aims to optimise use of antibiotics for Surgical Antibiotic Prophylaxis (SAP), began implementation in 2021 and has already made great progress. In addition, in February 2022, Georgia began implementing a further three projects across the human and animal health sectors.

Read more

ICARS field visit to Vietnam

At the end of May 2022, ICARS staff from the Science and Operations departments travelled to Vietnam to touch base with teams implementing projects, kick-start new initiatives and continue the co-development of new solutions aiming to mitigate antimicrobial resistance in both the human health and aquaculture sectors.

Read more

JPIAMR hosts start-up meeting for funded projects in the Interventions and Transmission call 2021

On 28th April 2022, the Joint Programming Initiative on AMR (JPIAMR) kickstarted 19 new One Health intervention and transmission projects to tackle antimicrobial resistance (AMR) around the world. Each project supported through the ERA-Net JPIAMR ACTION call brings together a range of research partners from different countries and fields of expertise, to develop and test innovative AMR solutions and promote cross-border research on AMR. Through this call, ICARS has committed 1,724,342 Euro to fund six research groups from low- and middle-income countries providing them with the opportunity to join larger cross-country consortia to tackle AMR across the One Health spectrum.

ICARS are currently implementing nine demonstration projects in Africa, Asia and Latin America across the One Health spectrum. In addition, we are also leading a range of complementary supporting activities to enhance existing initiatives and strengthen our impact.

Learn more about ICARS' project portfolio!

Our third strategic pillar is concerned with advocating for context-specific and cost-effective solutions for mitigating AMR in LMICs. Below we present a few highlights from our various outreach and advocacy activities over the past few months:

Article in ISAC & APUA Newsletter: Developing multi-disciplinary and context specific solutions to tackle antimicrobial resistance
Educational Workshop and Symposium at ECCMID 2022
ISAC Webinar: The fight against antimicrobial resistance: a luta continua!
JPIAMR roundtables: Supporting measures to mitigate AMR in One Health settings (Co-hosted by ICARS)
6th AMR Conference (Biocom): Parallel Track: Focus on One Health
Interview in Disease Models and Medicines Journal: Breaking the silos, stopping the spread: an interview with Jyoti Joshi